By MarketWatch |
February 18, 2020
Shares of Sanofi ADR were up 1% in trading on Monday after the French drugmaker announced plans to work on a vaccine for COVID-19, the new coronavirus that has sickened more than 73,000 people and led to the deaths of 1,873.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
A new personal protective equipment manufacturing company is set to open in Cincinnati next year.